Vernalis
Vernalis cough and cold drug knocked-back by FDA
August 7, 2017Sales and Marketing Vernalis, biotech, drugs, pharma, pharmaceutical, tris pharma
Vernalis has been given a second CRL for a cough and cold treatment by the FDA this year. The therapy, …
Vernalis diabetes pain drug fails in phase II
March 24, 2010Research and Development Vernalis
Vernalis’ new treatment for neuropathic pain has disappointed in phase II trials and will now be dropped for this indication. …
Vernalis and GSK sign risk-sharing deal
August 7, 2009Research and Development, Sales and Marketing Deals, GSK, Vernalis
Vernalis and GlaxoSmithKline have joined forces to work on a cancer treatment in a deal which could be worth more …
Servier signs drug discovery deal with Vernalis
May 7, 2009Research and Development, Sales and Marketing Servier, Vernalis
Servier, France's largest privately-owned pharma company, has signed a new three-year drug discovery deal with Vernalis focused on oncology. UK …
Vernalis takes diabetes pain drug into phase II
August 15, 2006Research and Development Vernalis
UK biotech company Vernalis has started enrolment into a phase II trial of V3381, a drug designed for patients with …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
